gemfibrozil

1. Antidiabetic Effect and Mechanisms of Gemfibrozil in Experimental Diabetes Mellitus Rats
   吉非罗齐对实验性糖尿病大鼠的降糖作用及其机制研究
2. Objective To explore the treatment effect and the possible mechanism of gemfibrozil ( Gem) in treating experimental fatty liver.
   目的：探讨以降低甘油三酯为主的调血脂药吉非贝齐（GemfibrozilGem）对脂肪肝的治疗作用及机制。
3. Bioequivalence and relative bioavailability of gemfibrozil tablets in the human body
   吉非罗齐片剂人体相对生物利用度及生物等效性
4. Enhanced PPAR α expression with gemfibrozil may decrease the levels of serm TG and FFA in high fat diet rats by regulating fatty acid metabolism related gene;
   使用吉非罗齐增强大鼠PPARα的表达，可能通过转录调节脂肪酸代谢相关基因来降低高脂大鼠血中甘油三脂和游离脂肪酸水平，不仅能预防高脂饲料诱发NAFL的发生；
5. Impact of Gemfibrozil on Nitric Oxide Activity and Cell Adherence of Hyperlipidemic Rats Nitric oxide activity in cultured bovine retinal capillary pericytes
   培养的牛视网膜毛细血管周细胞产生一氧化氮的影响
6. Tea-pigment vs gemfibrozil in treating hyperlipidemia and high uric acid in blood
   茶色素与吉非贝齐治疗高脂血症和高尿酸血症的比较
7. Observation of gemfibrozil treating hyperlipidemia in nephrotic syndrome of steroid-resistance
   诺衡对激素耐药型肾病综合征高脂血症疗效的初步观察
8. The Study of Transcriptional Regulation on Apo A ⅰ Gene by Estrogen and Gemfibrozil
   雌激素、吉非贝齐对载脂蛋白AⅠ基因转录调控作用的研究
9. Optimum formula of gemfibrozil capsules by orthogonal design
   吉非罗齐胶囊处方的优选
10. Gemfibrozil Determined in Serum by HPLC and Its Relative Bioavailability
    吉非罗奇的高效液相色谱测定及其相对生物利用度
11. The composition and processing of gemfibrozil capsules were selected with uniform design.
    采用均匀设计对吉非贝齐胶囊处方组成及制备工艺进行研究。
12. OBJECTIVE: The pharmacokinetics and relative bioavailability of Gemfibrozil capsules were studied.
    目的：对吉非罗齐胶囊的相对生物利用度和药物动力学进行研究。
13. The changes of acylation-stimulating protein and leptin levels in patients with hypertriglyceridemia after gemfibrozil treatment
    高三酰甘油血症患者调脂治疗前后酰化作用刺激蛋白和瘦素水平的变化
14. AIM: To study the impact of hyperlipidemia on vasoactive substances and the mechanism of gemfibrozil in regulating the endothelial function.
    目的：探讨高脂血症时血管活性物质的变化特点及调脂药物吉非罗齐对内皮依赖的舒张功能的影响机制。
15. Two-site absorption model fits fo pharmacokinetic data of gemfibrozil in man
    双部位吸收模型拟合吉非贝齐在人体中药代动力学数据
16. Experimental Study on The Treatment of Fatty Liver in Rats by Gemfibrozil
    吉非贝齐抗脂肪肝的实验研究
17. In this study, the metabolic stability of commonly used fibrates ( gemfibrozil, clofibrate, fenofibrate, bezafibrate) were investigated using rat and human liver microsomes.
    本课题研究了经常使用的几个贝特类药物（吉非罗奇、氯贝特、菲诺贝特、本扎贝特）在大鼠和人的肝微粒体中的代谢稳定性。

noun

1. medication (trade name Lopid) used to lower the levels of triglyceride in the blood

   Synonym:    Lopid